NorthWest Biotherapeutics Inc (NWBO)

[Poor Man -]

Their estate planning has been going on for years. Has nearly nothing to do with timing of milestones.

The clock is ticking. Where’s the cash coming from prior to the end of the tax year at midnight, December 31, 2023? Dilution remains a serious concern at 60 cents per share.

Maybe management wants to offer some meaningful guidance about what their plans might be at this stage, rather leaving everyone in the dark?

Let’s be honest, management just plain sucks. But let’s also hope they have enough wherewithal to get something closed “soon” for the benefit of both patients and shareholders.